Literature DB >> 19016740

Molecular changes in white matter adjacent to an active demyelinating lesion in early multiple sclerosis.

Thomas Zeis1, Alfonse Probst, Andreas Johann Steck, Christine Stadelmann, Wolfgang Brück, Nicole Schaeren-Wiemers.   

Abstract

A stereotactic biopsy of a 17-year-old woman revealed an active inflammatory demyelinating lesion compatible with pattern III multiple sclerosis (MS) according to Lucchinetti et al. The biopsy included a white matter region distant from the active inflammatory demyelinating lesion with abnormal MRI signal, lacking histopathological signs of demyelination and/or oligodendrocyte apoptosis. Expression analysis of this area revealed a strong up-regulation of neuronal nitric oxide synthase (nNOS). Furthermore, detection of nitrotyrosine provided evidence for reactive nitrogen species (RNS)-mediated damage to oligodendrocytes. Concomitantly, genes involved in neuroprotection against oxidative stress such as heme oxygenase 1 were up-regulated. Even though a single case report, this study shows earliest molecular changes in white matter surrounding an actively demyelinating lesion during the first manifestation of MS, pointing toward a more widespread pathological process. Therapeutic targeting of the identified mechanisms of tissue injury might be crucial to prevent further lesion formation or secondary tissue damage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19016740     DOI: 10.1111/j.1750-3639.2008.00231.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  29 in total

1.  In vitro and in vivo induction and activation of nNOS by LPS in oligodendrocytes.

Authors:  S Y Yao; A Ljunggren-Rose; N Chandramohan; W O Whetsell; S Sriram
Journal:  J Neuroimmunol       Date:  2010-08-19       Impact factor: 3.478

Review 2.  Systematic approaches to central nervous system myelin.

Authors:  Patricia de Monasterio-Schrader; Olaf Jahn; Stefan Tenzer; Sven P Wichert; Julia Patzig; Hauke B Werner
Journal:  Cell Mol Life Sci       Date:  2012-03-23       Impact factor: 9.261

3.  Changed histone acetylation patterns in normal-appearing white matter and early multiple sclerosis lesions.

Authors:  Xiomara Pedre; Fabrizio Mastronardi; Wolfgang Bruck; Gerardo López-Rodas; Tanja Kuhlmann; Patrizia Casaccia
Journal:  J Neurosci       Date:  2011-03-02       Impact factor: 6.167

Review 4.  As a painkiller: a review of pre- and postnatal non-steroidal anti-inflammatory drug exposure effects on the nervous systems.

Authors:  Kıymet Kubra Yurt; Suleyman Kaplan
Journal:  Inflammopharmacology       Date:  2017-12-27       Impact factor: 4.473

Review 5.  NO orchestrates the loss of synaptic boutons from adult "sick" motoneurons: modeling a molecular mechanism.

Authors:  Bernardo Moreno-López; Carmen R Sunico; David González-Forero
Journal:  Mol Neurobiol       Date:  2010-12-29       Impact factor: 5.590

Review 6.  Gene expression profiling in multiple sclerosis brain.

Authors:  Ranjan Dutta; Bruce D Trapp
Journal:  Neurobiol Dis       Date:  2010-12-13       Impact factor: 5.996

Review 7.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

8.  Inhibition of myeloperoxidase at the peak of experimental autoimmune encephalomyelitis restores blood-brain barrier integrity and ameliorates disease severity.

Authors:  Hao Zhang; Avijit Ray; Nichole M Miller; Danielle Hartwig; Kirkwood A Pritchard; Bonnie N Dittel
Journal:  J Neurochem       Date:  2015-11-30       Impact factor: 5.372

9.  The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis.

Authors:  Delinda A Johnson; Sara Amirahmadi; Charlotte Ward; Zsuszanna Fabry; Jeffrey A Johnson
Journal:  Toxicol Sci       Date:  2009-11-12       Impact factor: 4.849

Review 10.  Progressive multiple sclerosis: pathology and pathogenesis.

Authors:  Hans Lassmann; Jack van Horssen; Don Mahad
Journal:  Nat Rev Neurol       Date:  2012-09-25       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.